APA Clinical Practice Guidelines Development
Clinical practice guidelines provide research-based recommendations for the treatment of particular disorders. They generally include assessments of the strength of the current scientific evidence for each recommendation.
APA has not previously developed clinical treatment guidelines, but in 2010 initiated a process for producing such guidelines. (APA has previously produced professional practice guidelines which address psychological practice with particular populations or in particular areas without focusing on specific disorders or treatments.)
Advisory Steering Committee
An Advisory Steering Committee for the Development of Clinical Practice Guidelines, appointed by the APA Board of Directors, is overseeing the process of guidelines development. The members of the committee for 2011-2013 are:
- Steven D. Hollon, PhD, Vanderbilt University, Chair
- Patricia A. Areán, PhD, University of California, San Francisco
- Michelle G. Craske, PhD, University of California, Los Angeles
- Kermit A. Crawford, PhD, Boston University Medical Campus
- Daniel R. Kivlahan, PhD, University of Washington, Veterans Health Administration
- Jeffrey J. Magnavita, PhD, ABPP, Independent Practice, Glastonbury Medical Arts Center
- Thomas H. Ollendick, PhD, Virginia Polytechnic Institute and State University
- Thomas L. Sexton, PhD, ABPP, Indiana University
- Bonnie Spring, PhD, ABPP, Northwestern University
The Advisory Steering Committee is developing a Manual of Procedures to describe the process that APA is following for guidelines development.
Check back to this page for calls for nominations and comment and other news about APA’s treatment guidelines development process.
The Advisory Steering Committee's meeting agendas and minutes are posted.
Additional information can be obtained by contacting the Treatment Guidelines team (APA staff and Advisory Steering Committee members) by email.
